MAP2K1 and cancer: To confirm that PRIMA-1Met attenuated cancer cell proliferation and anchorage-independent growth via the inhibition of MEK kinase activity, we used shRNA to knockdown MEK1 expression in HCT116neg or HCT116wt cells (Figure 5A).